Assessment of efficacy and safety of the herbal medicinal product BNO 1016 in chronic rhinosinusitis

Abstract

Sinupret extract can safely be administered in patients with CRS. Although the primary endpoint of the study was not significant, a post-hoc subgroup analysis in patients whose disease was diagnosed by a specialist revealed a pronounced treatment effect. Effects in that subgroup were even stronger with longer disease persistence and stronger severity.